about
Pharmacological interventions for promoting smoking cessation during pregnancyPharmacological interventions for promoting smoking cessation during pregnancyAdverse effects of oral corticosteroids in relation to dose in patients with lung diseasePredictors of children's secondhand smoke exposure at home: a systematic review and narrative synthesis of the evidenceLongitudinal cohort survey of women's smoking behaviour and attitudes in pregnancy: study methods and baseline data.Lessons learned from the London Exercise and Pregnant (LEAP) Smokers randomised controlled trial process evaluation: implications for the design of physical activity for smoking cessation interventions during pregnancyComparison of cotinine levels in pregnant women while smoking and when using nicotine replacement therapyLarge multi-centre pilot randomized controlled trial testing a low-cost, tailored, self-help smoking cessation text message intervention for pregnant smokers (MiQuit).Effect of mouth taping at night on asthma control--a randomised single-blind crossover study.Pilot study to evaluate a tailored text message intervention for pregnant smokers (MiQuit): study protocol for a randomised controlled trial.Provision of smoking cessation support for pregnant women in England: results from an online survey of NHS Stop Smoking Services for Pregnant Women.The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy--clinical effectiveness and safety until 2 years after delivery, with economic evaluation.Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects.Effects of rac-albuterol on arterial blood gases in patients with stable hypercapnic chronic obstructive pulmonary diseaseSmoking in the home after childbirth: prevalence and determinants in an English cohort."I Was a Full Time Proper Smoker": A Qualitative Exploration of Smoking in the Home after Childbirth among Women Who Relapse Postpartum.Adaptation and uptake evaluation of an SMS text message smoking cessation programme (MiQuit) for use in antenatal carePoor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?Relation of pulmonary lymphangio-leiomyomatosis to use of the oral contraceptive pill and fertility in the UK: a national case control study.Changes in the rate of nicotine metabolism across pregnancy: a longitudinal study.The Association Between Treatment Adherence to Nicotine Patches and Smoking Cessation in Pregnancy: A Secondary Analysis of a Randomized Controlled TrialAntenatal Clinic and Stop Smoking Services Staff Views on "Opt-Out" Referrals for Smoking Cessation in Pregnancy: A Framework Analysis.Nicotine dependence and biochemical exposure measures in the second trimester of pregnancy.Factors associated with smoking cessation in early and late pregnancy in the smoking, nicotine, and pregnancy trial: a trial of nicotine replacement therapy.Efficacy and safety of nicotine replacement therapy for smoking cessation in pregnancy: systematic review and meta-analysis.Cost-Effectiveness of Nicotine Patches for Smoking Cessation in Pregnancy: A Placebo Randomized Controlled Trial (SNAP).'Opt-out' referrals after identifying pregnant smokers using exhaled air carbon monoxide: impact on engagement with smoking cessation support.Pregnant Women's Experiences and Views on an "Opt-Out" Referral Pathway to Specialist Smoking Cessation Support: A Qualitative Evaluation.Understanding Pregnant Smokers' Adherence to Nicotine Replacement Therapy During a Quit Attempt: A Qualitative Study.The Nicotine Metabolite Ratio in Pregnancy Measured by trans-3'-Hydroxycotinine to Cotinine Ratio: Characteristics and Relationship With Smoking Cessation.The impact of oral corticosteroid use on bone mineral density and vertebral fracture.Effect of 443c81, an inhaled mu-opioid receptor agonist in asthma.Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: follow-up from the randomised, double-blind, placebo-controlled SNAP trial.Smoking and quit attempts during pregnancy and postpartum: a longitudinal UK cohort.A randomized trial of nicotine-replacement therapy patches in pregnancy.Improving Behavioral Support for Smoking Cessation in Pregnancy: What Are the Barriers to Stopping and Which Behavior Change Techniques Can Influence These? Application of Theoretical Domains Framework.Uptake of Tailored Text Message Smoking Cessation Support in Pregnancy When Advertised on the Internet (MiQuit): Observational Study.Efficacy of nicotine replacement therapy in pregnancyComparison of nicotine exposure during pregnancy when smoking and abstinent with nicotine replacement therapy: systematic review and meta-analysisUptake of Tailored Text Message Smoking Cessation Support in Pregnancy When Advertised on the Internet (MiQuit): Observational Study
P50
Q24186969-FC1E8BEA-6D82-4727-8BC1-4012F6503157Q24200435-FE4ECE68-1CB5-4582-93DA-C0E09E42B4C7Q28360540-142D50BB-EB51-4A0D-860D-CF5C10DCB7C2Q28397721-97EA4861-6B97-4F7F-9F61-36963B683625Q30822001-C95BF901-056F-426F-843B-30417ED55817Q30835140-83CE2772-1FC6-4D96-8A2D-70562D3B1BAAQ33586449-344A95C5-5184-43C6-8957-2A3A0D1571DAQ33845785-0FA88418-1868-4D43-86DE-50418F7A4414Q34962444-7C795A6C-1781-4A77-BF20-7FD08B02A327Q35053574-EF444B28-D872-4E31-838F-7AB7E313396EQ35110127-F2B57175-6716-4FAB-90A0-99DA2CF2D047Q35232122-922AD04F-5842-4445-8035-F41A34120991Q35533937-08516496-8850-40AB-83B8-ACE808E4F0D9Q35827665-06033F29-5583-4808-AE9F-E237C0B80F5DQ36039143-993B8097-F9CE-4BE0-BCDA-D5788B3A2F68Q36053864-563C24C4-A666-44F0-BB52-61038EFA6DA2Q36205107-127004E5-9E74-4C6F-9AA5-AB18AD614B91Q36288427-8151ECC0-A6DC-49E6-B466-E8A97271CC4AQ36575291-0D6BAF79-B861-44BA-8CFD-D64BB870AF5FQ37238265-D76E0E08-2280-4A71-B27B-3385EE452DECQ37243509-341D9CDD-729A-4FA2-9E45-BBA23C5011FEQ37379184-1CD25953-0522-4CC0-9409-165032A0FD31Q37431234-27999776-85E8-4608-8E92-432A827328A2Q37637589-BECADD1F-ED7C-4185-8F06-FE2A51503131Q37807467-7C01EF48-E7EC-4AC6-9A4C-DFDFE1027AA7Q39081082-0C9D6A89-178C-4353-BD6F-5DC553B03D82Q39736440-888C1D3B-2DAB-469B-B59C-CD39D52FFAE5Q40131098-FC0A3919-6013-41DC-B986-0303563E52E4Q40517592-CD32C9D0-F818-4604-B25D-3EC68CFC97C0Q41581615-E4E07680-E758-4A83-89D2-2900D7F5FDB5Q44120915-84618FEC-C530-4EF5-8308-575CDC1E80CAQ44338661-9E0F834A-A482-4735-A71C-7CEA02C613EFQ44595791-372EDBF3-1A6F-42C2-8519-71BDF9F996F5Q47132635-1057381D-3E7C-4C61-B27D-E2945B32EC17Q47577222-A867DF9C-DB27-4792-B01F-086466BD2299Q49804475-D9FDFABA-C0B5-4F16-ACD7-023E50CD43EBQ53406416-4C8F2636-DDC4-4ECD-B719-C6312CCD7FE9Q57341558-CA041987-F3C2-41D6-9EB7-AF7AAC8A2A95Q57467851-7B121A7C-6E9F-4991-96FD-911ED16E0AFBQ57478529-1DA500B1-7B35-406E-867B-12993C042934
P50
description
Brits onderzoekster
@nl
investigadora británica
@ast
researcher in the field of medicine
@en
name
Sue Cooper
@ast
Sue Cooper
@ca
Sue Cooper
@en
Sue Cooper
@es
Sue Cooper
@fr
Sue Cooper
@nl
Sue Cooper
@sl
type
label
Sue Cooper
@ast
Sue Cooper
@ca
Sue Cooper
@en
Sue Cooper
@es
Sue Cooper
@fr
Sue Cooper
@nl
Sue Cooper
@sl
prefLabel
Sue Cooper
@ast
Sue Cooper
@ca
Sue Cooper
@en
Sue Cooper
@es
Sue Cooper
@fr
Sue Cooper
@nl
Sue Cooper
@sl
P1053
A-7471-2011
P106
P1153
14419818900
P21
P31
P3829
P496
0000-0002-1994-6395